SIGN YOUR ORGANIZATION’S NAME TO THE LETTER TO SUPPORT THE 2017 AFFORDABLE & SAFE PRESCRIPTION DRUG IMPORTATION ACT
Join the growing number of consumer, health and social justice organizations in signing Prescription Justice’s coalition letter to members of Congress in support of allowing Americans to obtain lower cost and safe medications from Canada and other countries.
The letter specifically calls for the passage of the 2017 Safe and Affordable Prescription Drug Importation Act. The Act would expressly allow importation of lower cost medications from Canada, and, after two years, other countries with strong pharmaceutical regulations. The joint letter to Congress also recognizes that Americans already import medication for personal use, regardless of the federal restrictions, often ordering from international online pharmacies.
Passing drug importation legislation is just one important step of many to come in bringing an end to the crisis of high drug prices in America, and it’s time we took that step together!
This form is for organizations, not individuals. By filling out this form and listing your organization, you are indicating that you have permission to sign your organization to a letter being sent to Congress or the executive branch.
Signatories To The Prescription Justice Letter To Congress Supporting The Affordable And Safe Prescription Drug Importation Act
Alliance for Retired Americans
American Federation of Teachers
American Society on Aging
Campaign for Personal Prescription Importation
Center for Medicare Advocacy
Doctors for America
Economic Policy Institute Policy Center
IL Chapter – Area Health Education Centers
Justice in Aging
National Association for Hispanic Elderly [Asociación Nacional Pro Personas Mayores]
National Committee to Preserve Social Security and Medicare
National Nurses United
National Organization for Women
Our Revolution – St. Joseph, Mo.
People Demanding Action
People of Faith for Access to Medicines
Social Security Works
The Workers United Retiree Association
Unfinished Business Foundation
Stay informed about news and advocacy centered on the crisis of high drug prices